Lead- and device-related complications in the Antiarrhythmics Versus Implantable Defibrillators Trial

Background Implantation of transvenous implantable cardioverter defibrillators (ICDs) by use of a nonthoracotomy approach has become routine therapy for survivors of life-threatening tachyarrhythmias. The purpose of this study was to identify and prospectively characterize the frequency of lead- and...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2001-01, Vol.141 (1), p.92-98
Main Authors: Kron, Jack, Herre, John, Renfroe, Ellen Graham, Rizo-Patron, Carlos, Raitt, Merritt, Halperin, Blair, Gold, Michael, Goldner, Bruce, Wathen, Mark, Wilkoff, Bruce, Olarte, Anna, Yao, Qing
Format: Article
Language:English
Subjects:
Anti-Arrhythmia Agents - therapeutic use
Biological and medical sciences
Defibrillators, Implantable - adverse effects
Diseases of the cardiovascular system
Equipment Design
Female
Humans
Lead
Male
Medical sciences
Middle Aged
Prospective Studies
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Tachycardia - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Implantation of transvenous implantable cardioverter defibrillators (ICDs) by use of a nonthoracotomy approach has become routine therapy for survivors of life-threatening tachyarrhythmias. The purpose of this study was to identify and prospectively characterize the frequency of lead- and ICD-related complications from the Antiarrhythmics versus Implantable Defibrillators (AVID) Trial. Methods and Results Between June 1, 1993, and April 7, 1997, 539 patients received nonthoracotomy ICDs either as initial treatment assignment (477) or as crossover from medical management (62). A total of 62 first complications occurred. The subclavian route of insertion resulted in more complications than the cephalic vein route, 46 of 339 (14%) versus 6 of 135 (4%), P =.005, as did the abdominal versus pectoral generator site, 31 of 238 (13%) versus 17 of 291 (6%), P
ISSN:0002-8703
1097-6744
DOI:10.1067/mhj.2001.111261